Kyverna Therapeutics, Inc. (KYTX) Tops Q1 EPS by 38c

Kyverna Therapeutics, Inc. (NASDAQ: KYTX) reported Q1 EPS of ($0.66), $0.38 better than the analyst estimate of ($1.04).

For earnings history and earnings-related data on Kyverna Therapeutics, Inc. (KYTX) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance
• Palo Alto Networks (PANW) Tops Q4 EPS by 4c, Offers Guidance